Pharmacokinetic data regarding the penetration of circulating rEpo into brain tissue is needed to optimize neuroprotective strategies. We sought to determine the pharmacokinetics of rEpo given ...

MSD has reported positive topline outcomes from the Phase III study of subcutaneous pembrolizumab in conjunction with ...

Thursday, Adial Pharmaceuticals Inc (NASDAQ:ADIL) said it has completed a pharmacokinetics (PK) study of AD04 for Alcohol Use ...

Eupraxia Pharmaceuticals (EPRX)unveiled new pharmacokinetic, or PK data from its Phase 2a Eosinophilic Esophagitis, or EoE, program.

Amgen (NASDAQ:AMGN) today announced positive data at 52 weeks in a double-blind, dose-ranging Phase 2 study with MariTide ...

Spyre Therapeutics (SYRE) announced positive interim Phase 1 data from its first-in-human trial of SPY001, an investigational novel, extended ...